NFKB1 and Alzheimer disease: Pinocembrin has been proved to have protective effect on microvascular function via reducing the cytotoxicity induced by fibrillar Aβ1-40 and inhibiting the mitogen-activated protein kinase (MAPK)/NF-κB inflammatory signaling pathways in hBMECs in AD models (Liu et al., 2014).